Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04070846 · ClinicalTrials.gov registry record · Phase 1
Mass Balance Study of [14C]LC350189 in Healthy Volunteers
A Phase 1 study, sponsored by LG Chem.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04070846 is a Phase 1 study that has completed, run by LG Chem. The registered enrollment target is 6 participants.
The verdict
NCT04070846, a Phase 1 study, has completed, sponsored by LG Chem.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a Phase 1, open-label, single-dose, mass balance study designed to evaluate the absorption, metabolism, and excretion of \[14C\] radiolabeled LC350189 after oral administration.
Interventions
- DRUG [14C] LC350189
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2020-03-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04070846
The ClinicalTrials.gov registry entry for NCT04070846 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LG Chem, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14C] LC350189 is the first listed.
NCT04070846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04070846 about?
NCT04070846 is a clinical study titled "Mass Balance Study of [14C]LC350189 in Healthy Volunteers". This is a Phase 1, open-label, single-dose, mass balance study designed to evaluate the absorption, metabolism, and excretion of \[14C\] radiolabeled LC350189 after oral administration.
What is the current status of trial NCT04070846?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2020-02-26. Estimated completion is 2020-03-07.
What interventions are being tested in trial NCT04070846?
The interventions under investigation include: [14C] LC350189 (DRUG).
Who is sponsoring clinical trial NCT04070846?
This trial is sponsored by LG Chem, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.